Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
HanAll Biopharma is a biopharmaceutical company primarily engaged in the research and development, manufacturing, and sale of pharmaceuticals. The company focuses on developing innovative new drugs, particularly treatments for autoimmune diseases, ophthalmic conditions such as dry eye disease, and neurological disorders. Notably, its pipeline includes biopharmaceutical new drugs such as HL161B12 for autoimmune diseases and HL036 for dry eye disease.
한올바이오파마는 의약품 연구개발, 제조 및 판매를 주요 사업으로 영위하는 바이오 제약 기업입니다. 자가면역질환, 안구건조증 등 안과 질환, 신경계 질환 치료제를 중심으로 혁신 신약 개발에 집중하고 있습니다. 특히 자가면역질환 치료제 HL161B12와 안구건조증 치료제 HL036 등의 바이오 신약 파이프라인을 보유하고 있습니다.
